Wyse, PhD, Jessica J., Benjamin J. Morasco, PhD, Steven K. Dobscha, MD, Michael I. Demidenko, BS, Thomas H. A. Meath, MPH, and Travis I. Lovejoy, PhD, MPH. “Provider Reasons for Discontinuing Long-Term Opioid Therapy Following Aberrant Urine Drug Tests Differ Based on the Type of Substance Identified”. Journal of Opioid Management 14, no. 4 (July 1, 2018): 295–303. Accessed November 22, 2024. https://wmpllc.org/ojs/index.php/jom/article/view/1798.